HealthStream stock holds steady as Faircurve sees limited upside

Published on 09/20/2026 at 15:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HealthStream stock closed at USD 29.23 on September 19, 2026, only 3.8% above Faircurve’s model fair value. The shares carry a market value of USD 854 million, putting the healthcare information services provider in mid-cap territory.

HSTM, US42224G1013, Illustration mit AI erstellt.

HealthStream, Inc. (ISIN US42224G1013) stock closed at USD 29.23 as of September 19, 2026, with the shares trading near what one quantitative model views as fair value for the healthcare information services specialist. According to Faircurve on September 19, 2026, the model fair value for HealthStream is USD 28.13 per share, implying the stock trades about 3.8% above this estimate and carries a market value of roughly USD 854 million.

Valuation signal from Faircurve model

In its September 2026 sector overview, Faircurve ranks HealthStream in the healthcare information services category with a last close of USD 29.23 and a model-derived fair value of USD 28.13 per share.Faircurve The gap of negative 3.8% indicates that, within this framework, HealthStream is classified as fairly valued rather than materially undervalued or overvalued, which can be an important reference point for investors comparing mid-cap healthcare technology names.

The same Faircurve table lists HealthStream’s quality score at 72 and its market value at USD 854 million as of the September 19, 2026 close.Faircurve While the model does not publish detailed financial metrics in this snippet, the combination of a mid-range valuation gap and a relatively high quality score suggests that HealthStream is viewed as a solid operator with limited mispricing according to this specific quantitative approach.

Mid-cap profile in healthcare technology

HealthStream focuses on delivering workforce development and quality improvement solutions to healthcare providers, positioning the company in the healthcare information services segment where recurring software and service revenues are common. The Faircurve overview underscores this classification and places HealthStream among mid-cap peers with similar business models.Faircurve For investors, that segment label matters because valuation and growth expectations often differ from traditional hospital or device companies, and the fair value estimate reflects sector-specific assumptions.

Although the Faircurve data do not break out HealthStream’s latest quarterly revenue or earnings figures in the available snippet, the company’s market value of USD 854 million as of September 19, 2026 shows that it remains firmly in mid-cap territory.Faircurve In practical terms, this means that HealthStream can still offer meaningful growth potential compared with large-cap healthcare technology names, but without the liquidity and index weight of the biggest players.

Stock price level and investor perspective

With HealthStream stock at USD 29.23 on September 19, 2026 and a model fair value of USD 28.13 from Faircurve’s healthcare sector research, the difference of just over 1 dollar per share underscores how closely the market price currently tracks this particular valuation benchmark.Faircurve For investors, the key question is whether upcoming operational milestones or financial reports can shift that balance by driving either faster earnings growth or changes in sentiment.